Quality of Chronic Anticoagulation Control in Patients with Intracranial Haemorrhage due to Vitamin K Antagonists

about

Quality of Chronic Anticoagulation Control in Patients with Intracranial Haemorrhage due to Vitamin K Antagonists

Item

http://www.wikidata.org/entity/Q58803005

description

scientific article published on 02 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Quality of Chronic Anticoagula ...... e due to Vitamin K Antagonists

@en

Quality of Chronic Anticoagula ...... e due to Vitamin K Antagonists

@nl

type

Item

label

Quality of Chronic Anticoagula ...... e due to Vitamin K Antagonists

@en

Quality of Chronic Anticoagula ...... e due to Vitamin K Antagonists

@nl

prefLabel

Quality of Chronic Anticoagula ...... e due to Vitamin K Antagonists

@en

Quality of Chronic Anticoagula ...... e due to Vitamin K Antagonists

@nl

P1476

Quality of Chronic Anticoagula ...... e due to Vitamin K Antagonists

@en

P2093

Antonio Cruz-Culebras

http://www.w3.org/2001/XMLSchema#string

Consuelo Matute

http://www.w3.org/2001/XMLSchema#string

Elena Viedma-Guiard

http://www.w3.org/2001/XMLSchema#string

Leticia Crespo-Araico

http://www.w3.org/2001/XMLSchema#string

Maria Molina-Sanchez

http://www.w3.org/2001/XMLSchema#string

Pablo Agüero-Rabes

http://www.w3.org/2001/XMLSchema#string

Rocio Vera

http://www.w3.org/2001/XMLSchema#string

Rodrigo Alvarez-Velasco

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation

Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study.

Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression.

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.

Relationship between time in therapeutic range and comparative treatment effect of rivaroxaban and warfarin: results from the ROCKET AF trial.

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.

Epidemiology of Intracranial Haemorrhages Associated with Vitamin K Antagonist Oral Anticoagulants in Spain: TAC Registry.

Warfarin and intracranial haemorrhage.

P304

5613103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2018/5613103

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

Carlos Estévez-Fraga

J Masjuan

Alicia De Felipe-Mimbrera

P577

2018-08-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30174820

http://www.w3.org/2001/XMLSchema#string

P921

vitamin K

vitamin

anticoagulation

P932

6098890

http://www.w3.org/2001/XMLSchema#string